Literature DB >> 30535943

The effectiveness of mouthwashes in alleviating radiation-induced oral mucositis in head and neck cancer patients: a systematic review.

Masaru Konishi1, Rinus Gerardus Verdonschot2, Kiichi Shimabukuro2, Takashi Nakamoto3, Minoru Fujita2, Naoya Kakimoto2.   

Abstract

OBJECTIVE: The aim of the study was to perform a systematic literature search and meta-analysis to reveal the most effective mouthwash for head and neck cancer patients who are experiencing radiation therapy-induced mucositis.
METHODS: Using two electronic databases, a literature search and data interpretation were systematically performed as follows: (i) problem specification, (ii) devising of a literature search plan, (iii) literature search and retrieval of publications, and (iv) meta-analysis and data interpretation. The main problem was specified as follows: what mouthwash is effective in alleviating oral mucositis for head and neck cancer patients who are undergoing radiotherapy?
RESULTS: The literature search yielded 354 titles and abstracts. After reviewing the extracted literature, 25 publications met the inclusion criteria for this study and 17 of 25 were eventually evaluated in the meta-analysis.
CONCLUSION: The results of the meta-analysis indicated that the use of a mouthwash that includes anti-inflammatory properties contributes the most to alleviating oral mucositis in patients who are undergoing radiotherapy to treat head and neck cancer.

Entities:  

Keywords:  Head and neck neoplasms; Mouthwash; Oral mucositis; Radiotherapy

Year:  2018        PMID: 30535943     DOI: 10.1007/s11282-018-0361-9

Source DB:  PubMed          Journal:  Oral Radiol        ISSN: 0911-6028            Impact factor:   1.852


  34 in total

1.  A double-blind, placebo-controlled, randomised trial of active manuka honey and standard oral care for radiation-induced oral mucositis.

Authors:  Joy Bardy; Alex Molassiotis; W David Ryder; Kathleen Mais; Andrew Sykes; Beng Yap; Lip Lee; Ed Kaczmarski; Nicholas Slevin
Journal:  Br J Oral Maxillofac Surg       Date:  2011-06-01       Impact factor: 1.651

2.  Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study.

Authors:  Atul Sharma; G K Rath; S P Chaudhary; Alok Thakar; Bidhu Kalyan Mohanti; Sudhir Bahadur
Journal:  Eur J Cancer       Date:  2011-07-06       Impact factor: 9.162

3.  Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash.

Authors:  O Nicolatou-Galitis; K Dardoufas; P Markoulatos; A Sotiropoulou-Lontou; K Kyprianou; G Kolitsi; G Pissakas; C Skarleas; V Kouloulias; V Papanicolaou; N J Legakis; A Velegraki
Journal:  J Oral Pathol Med       Date:  2001-09       Impact factor: 4.253

4.  A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.

Authors:  Andy Trotti; Adam Garden; Padraig Warde; Paul Symonds; Corey Langer; Rebecca Redman; Thomas F Pajak; Tomas R Fleming; Michael Henke; Jean Bourhis; David I Rosenthal; Elizabeth Junor; Anthony Cmelak; Finbarr Sheehan; Janis Pulliam; Patricia Devitt-Risse; Henry Fuchs; Mark Chambers; Brian O'Sullivan; K Kian Ang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-01       Impact factor: 7.038

5.  Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.

Authors:  Susan A McCloskey; Wainwright Jaggernauth; Nestor R Rigual; Wesley L Hicks; Saurin R Popat; Maureen Sullivan; Terry L Mashtare; Mohamed K Khan; Thom R Loree; Anurag K Singh
Journal:  Am J Clin Oncol       Date:  2009-12       Impact factor: 2.339

6.  SAMITAL® improves chemo/radiotherapy-induced oral mucositis in patients with head and neck cancer: results of a randomized, placebo-controlled, single-blind Phase II study.

Authors:  D Pawar; R S Neve; S Kalgane; A Riva; E Bombardelli; M Ronchi; G Petrangolini; P Morazzoni
Journal:  Support Care Cancer       Date:  2012-09-04       Impact factor: 3.603

7.  Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2016-10-08       Impact factor: 79.321

8.  Double-blind, randomized pilot study of bioadhesive chlorhexidine gel in the prevention and treatment of mucositis induced by chemoradiotherapy of head and neck cancer.

Authors:  Rosa-Maria Diaz-Sanchez; Jerónimo Pachón-Ibáñez; Fátima Marín-Conde; Ángela Rodríguez-Caballero; Jose-Luis Gutierrez-Perez; Daniel Torres-Lagares
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-05-01

9.  Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.

Authors:  T Yokota; T Ogawa; S Takahashi; K Okami; T Fujii; K Tanaka; S Iwae; I Ota; T Ueda; N Monden; K Matsuura; H Kojima; S Ueda; K Sasaki; Y Fujimoto; Y Hasegawa; T Beppu; H Nishimori; S Hirano; Y Naka; Y Matsushima; M Fujii; M Tahara
Journal:  BMC Cancer       Date:  2017-05-05       Impact factor: 4.430

Review 10.  Radiation-Induced Oral Mucositis.

Authors:  Osama Muhammad Maria; Nicoletta Eliopoulos; Thierry Muanza
Journal:  Front Oncol       Date:  2017-05-22       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.